AzTrials
AzTrials

Cornelia de Lange SyndromeNCT05829668

Behavioral Assessment and Treatment of Problem Behavior in Children With Cornelia de Lange Syndrome

A study testing ABA-based functional analysis and treatment in people with Cornelia de Lange Syndrome, run by Hugo W. Moser Research Institute at Kennedy Krieger, Inc. at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goals of this clinical trial are to identify factors associated with the development of problem behavior in Cornelia de Lange syndrome (CdLS) and to develop an effective behavioral assessment and treatment model for problem behavior in children with CdLS. The hypotheses are as follows: 1. Read more about this study

Who is it for?
Ages 3 to 15 yearsHealthy volunteers can take part
Conditions the study is for
Cornelia de Lange Syndrome
What is being tested?
ABA-based functional analysis and treatment
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteUnited States
Study dates
2 Aug 2023to 31 Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 3 to 15 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Child with CdLS and problem behavior:
  • clinical diagnosis of CdLS confirmed;
  • age 3 to 15 years;
  • is English-speaking;
  • exhibits SIB, aggression, and/or disruptive behavior; and
  • is able to participate in several hours of assessment/treatment.
Show all 17Show fewer
  • Parent of child with CdLS is English-speaking and is willing to:
  • attend 2 full-day and one half-day clinic visits;
  • complete and return study measures; and
  • implement a behavior plan.
  • Child with CdLS without problem behavior:
  • clinical diagnosis of CdLS confirmed;
  • is English-speaking
  • age 3 to 15 years; and
  • child's age and adaptive functioning level matches that of a child in the treatment group
  • Parent of child with CdLS is English-speaking and willing to:
  • complete and return study measures.

Who cannot join

  • Child with CdLS:
  • does not exhibit SIB, aggression, or disruptive behavior;
  • child is younger than 3 years or older than 15 years;
  • is not English-speaking;
  • has severe SIB that produces significant tissue damage or requires protective equipment;
  • has uncontrolled seizures; or
Show all 14Show fewer
  • has medical conditions or requires time-intensive medical care that limits attendance or participation.
  • Parent of child with CdLS is not English-speaking or is not willing to complete study procedures.
  • Child with CdLS:
  • exhibits SIB, aggression, or disruptive behavior;
  • is younger than 3 years or older than 15 years;
  • is not English-speaking;
  • age and adaptive functioning level do not match that of a child in the treatment group.
  • Parent of child with CdLS is not English-speaking or willing to complete study procedures.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Patricia F Kurtz, PhD contact

443-923-2894

kurtz@kennedykrieger.org

Michelle D Chin, MS, MPH contact

443-923-9467

chin@kennedykrieger.org

United States1 site, 1 recruiting
  • Kennedy Krieger Institute

    Baltimore, Maryland, 21205

    Michelle Chin, MS, MPH, 443-923-9467, chin@kennedykrieger.org

    Patricia Kurtz, PHD, 443-923-2894, kurtz@kennedykrieger.org

    Recruiting

Other trials in United States

About this study

The goals of this clinical trial are to identify factors associated with the development of problem behavior in Cornelia de Lange syndrome (CdLS) and to develop an effective behavioral assessment and treatment model for problem behavior in children with CdLS.

The hypotheses are as follows:

Read more
  1. Based on pilot data, the investigators hypothesize that individuals with CdLS will exhibit preferences for auditory stimuli relative to other categories (e.g., visual, tactile) of stimuli.
  2. Based on pilot data, the investigators hypothesize that individuals with CdLS will exhibit problem behavior to obtain adult attention or to escape task demands relative to tangible and control conditions, as measured by functional analysis results.
  3. Function-based behavioral treatments will reduce problem behavior in individuals with CdLS by 80% or greater relative to baseline rates.
  4. Individuals with CdLS and problem behavior will exhibit more impaired communication, demonstrate increased emotion dysregulation, and exhibit more severe symptoms of Autism Spectrum Disorder (ASD) relative to those with CdLS and no problem behavior.

Participants in the intervention group (families of children with CdLS and problem behaviors) will be asked to complete study measures and attend 2 full days and one half-day of clinic services at Kennedy Krieger Institute so that the study team can provide assessment and treatment of child problem behaviors, and then train parents to apply the intervention. Participants in the control group (families of children with CdLS and no problem behavior) will be asked to complete study measures once every 3 months for a 2-year period to monitor the children.

This study will improve the ability to effectively treat problem behavior is CdLS, as well as identify key variables associated with problem behavior in CdLS which may be examined in future studies and clinical practice to foster early intervention and prevention efforts.

Read the detailed description

The presence of problem behavior such as self-injury and aggression is a prominent and challenging feature of Cornelia de Lange syndrome (CdLS). Despite the growing body of research on behavior problems associated with behavioral phenotypes in genetic disorders, problem behavior in this population is not well understood. For example, individuals with CdLS are at high risk for developing self-jury, however it is not known why some do not develop this problem behavior. Additionally, few studies have examined environmental influences on problem behavior in CdLS. The field of applied behavior analysis (ABA) offers precise assessment methods that have led to an increased understanding of problem behavior, and improved treatment outcomes for individuals with intellectual and developmental disabilities (IDD). In particular, functional analysis procedures are considered the most rigorous method for determining what variables serve to maintain problem behavior; thereby, leading to the prescription of effective individualized treatments. However, there are only a few cases reported in the literature of functional analysis of problem behavior in CdLS. Preliminary findings from functional analyses and other assessments in CdLS indicate differences in forms of problem behavior, functions for problem behavior, and responsiveness to certain classes of stimuli, relative to other genetic disorders. Previous literature and preliminary data suggest that variables associated with certain genetic conditions may impact form, function, and responsiveness to treatment for problem behavior. Thus, the goals of this clinical trial are to 1) to identify key variables associated with problem behavior in CdLS by comparing children with and without problem behavior across multiple variables including language ability, stimulus preferences, emotion dysregulation, and presence of autism; and 2) evaluate the effectiveness of an outpatient model of ABA-based assessment and treatment for children with CdLS exhibiting problem behavior; and 3) follow children with CDLS without problem behavior over a period of 2 years to begin to obtain information about what variables lead to the emergence of problem behavior, and to apply early intervention strategies.

Individualized function-based treatments will be evaluated with each participant using single-case experimental designs. Assessment and treatment data from all participants will also be combined to evaluate program outcomes within a consecutive controlled case series design. This type of study design minimizes potential selection bias favoring positive outcomes by including all participants encountered regardless of outcome. All participants will complete standardized measures of preference, adaptive skills, problem behavior, ASD, and emotion dysregulation. Program outcomes will also be evaluated using statistical analysis methods with consultation from the Intellectual and Developmental Disabilities Research Center (IDDRC) Behavioral Phenotyping Core at the Kennedy Krieger Institute/Johns Hopkins University. Parent responses on study measures will be combined to evaluate satisfaction with treatment and with services.

Treatment Group

Pre-Visit Assessments

  1. Parent will be asked to complete research measures at home including: Vineland Adaptive Behavior Scales (VABS-3) caregiver rating form, which is a standardized measure that provides developmental scores for communication skills, daily living skills, and socialization skills; Emotional Dysregulation Inventory (EDI) which is a caregiver-report questionnaire designed to capture emotional distress and problems with emotion regulation in both minimally verbal and verbal individuals; the Behavior Problem Inventory (BPI) which is a 49-item parent-completed instrument designed to measure the frequency and severity of a child's self-injurious, aggressive/destructive, and stereotypic behaviors; the Repetitive Behavior Scale-Revised (RBS-R), a 44-item inventory which measures the presence of repetitive and stereotypic behaviors in individual with ASD; the Aberrant Behavior Checklist (ABC), a 58-item inventory designed to measure a variety of emotional and behavior difficulties in individuals with IDD; and the Gilliam Autism Rating Scale: 2nd Edition (GARS). Completed measures will be mailed back to the study team.
  2. Parent will be asked to provide any records or reports related to problem behavior including functional behavioral assessment, behavioral intervention plan, or behavioral data regarding previous or current behavioral services.
  3. After parent returns measures by mail, a study team member will conduct a parent interview by phone to complete the Reinforcer Assessment Inventory for the Severely Disabled (RAISD); and the Functional Analysis Interview.

Study Visit at Kennedy Krieger Institute (KKI)/Day 1

  1. For any child with self-injurious behavior (SIB), the team will administer the Self-Injury Trauma scale (SIT), which is designed to quantify the amount of tissue damage associated with SIB.
  2. Conduct paired choice preference assessment to identify rank order of preferred stimuli that may be used in treatment.
  3. Conduct a functional analysis to identify environmental variables maintaining child problem behavior. Sessions will be conducted in accordance with a standard protocol in use by the Neurobehavioral Unit Outpatient clinic (NBU OPC), including conditions that test for social functions of problem behavior. The study team will video-record these sessions.

Study Visit at KKI/Day 2

  1. Study team and parent meet to discuss assessment findings and plan for treatment evaluation.
  2. Conduct treatment evaluation of function-based intervention. Treatment options are within the standard of care in the NBU OPC. The study team will video-record these sessions.
  3. Parent completes the Intervention Rating Profile-15, a 15-item measure of treatment acceptability.
  4. Train parent to implement behavioral treatment, using standard procedures within the NBU OPC.
  5. Parent completes the Intervention Rating Profile-15 and the Family Satisfaction Survey.
  6. Follow-up phone call: (1 week post treatment) to assess child progress. The study team will also provide a brief summary of the child's preferred items /activities, and a summary of the results from the questionnaires the parent completed.

Study visit at KKI/Follow Up (2 weeks post treatment): During a 3-hour study visit, the continued effectiveness of the behavior plan and parent implementation of such will be assessed via direct observation of parent and child. The study team will video-record these sessions. Results will be reviewed with the family. Parents will also complete the ABC and BPI.

Follow-up phone calls at 4, 8, and 12 weeks post treatment. Refer for additional services if necessary.

Control Group

Once ages and adaptive functioning levels of treatment group participants are established, recruitment for matched controls will be initiated. Investigators will seek to identify children with CdLS between the ages of 3 and 15 years who do not exhibit self-injurious behavior, aggression, or disruptive behavior. Parents of potential participants will be asked to participate in 2 phone interviews. In the first phone interview, a parent will be asked a series of questions to rule out the presence of child problem behavior. Once it is determined that the child does not exhibit problem behavior, parents will be asked if they would like to participate in the study. After the family has consented, the study team will mail the VABS-3 for completion. If VABS-3 results match that of a treatment group participant, a second phone interview will be conducted to complete the RAISD. The BPI, ABC, RBS-R, GARS, and EDI will be mailed. Local families will be invited to attend a 2-hr clinic visit for preference assessments. To monitor for emergence of problem behavior in the control group, the BPI and EDI will be repeated every 3 months for up to 2 yrs. If such behavior does emerge, clinical services will be offered to the participant and family at no cost.

Being tested
ABA-based functional analysis and treatment
Keywords
behavioral assessment, behavioral treatment, problem behavior
Medical subject headings
De Lange Syndrome, Problem Behavior

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ABA-based functional analysis and treatmentBehavioural

    Functional analysis to identify environmental variables maintaining child problem behavior and function-based treatment

Study groups in NCT05829668
Study groupRoleWhat they receive
ABA-based functional analysis and treatmentExperimentalAssessment and Treatment for problem behavior exhibited by children with CdLS
Receives: Behavioral: ABA-based functional analysis and treatment
No Problem behavior Control GroupNo interventionQuarterly Monitoring of children with CdLS that do not exhibit problem behavior

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Behavior Problems Inventory (BPI) scores

    The investigators will also quantify changes in problem behavior following the intervention relative to baseline with the normalized scores on the Behavior Problems Inventory (BPI). This scale has two sections: scores on Frequency of problem behavior (with a maximum score of 208 and a minimum score of zero) and scores on the Severity of problem behavior (with a maximum score of 156 and a minimum score of zero). Higher scores on these sections indicate worse outcomes, so decreases in the scores from pre-intervention to post-intervention would be indicative of a therapeutic outcome.

    Measured: pre-intervention (prior to admission) to post-intervention (at 2-week follow-up visit)

  2. Change in Aberrant Behavior Checklist (ABC) scores

    The investigators will also quantify changes in problem behavior following the intervention relative to baseline with the normalized scores on the Aberrant Behavior Checklist (ABC). The ABC has 5 subscales: Irritability, Social Withdrawal, Stereotypic Behavior, Hyperactivity/Noncompliance, and Inappropriate Speech. Scores on the Irritability subscale (maximum of 45 and a minimum of zero), in particular, would be indicative of problem behavior. Higher scores on this subscale indicate worse outcomes, so decreases in this scale scores from pre-intervention to post-intervention would be indicative of a therapeutic outcome.

    Measured: pre-intervention (prior to admission) to post-intervention (at 2-week follow-up visit)

Secondary outcomes (1)
  1. direct observation of problem behavior reduction

    The goal of this clinical trial is to decrease problem behavior (e.g., aggression, tantrums) in children and adolescents with CdLS. The investigators will measure behavioral changes using a multidimensional approach. One measure is derived from direct observation of problem behavior during baseline (i.e., before the intervention) and at the conclusion of the treatment (i.e., after the intervention). The mean rate of problem behavior at the conclusion of treatment will be subtracted from the mean rate of problem behavior during baseline. This quantity will be divided by the mean rate of problem behavior during baseline, then multiplied times 100 to convert to a percentage. A common clinical benchmark using this design is an 80% reduction in problem behavior for successful treatments. Thus, treatments that reduce problem behavior by less than 80% are said to be ineffective.

    Measured: over the course of 2 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Apr 2023
  2. Study start2 Aug 2023
  3. Primary completion31 Aug 2026 (estimated)
  4. Study completion31 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05829668
Sponsor's protocol ID
IRB00223332
Status last verified
Oct 2025
First submitted
14 Feb 2023
Last updated
29 Oct 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Aman, M. G., & Singh, N. (2017). The aberrant behavior checklist. East Aurora, NY: Slosson Educational Publications.

  • Arron K, Oliver C, Hall S, Sloneem J, Forman D, McClintock K. Effects of social context on social interaction and self-injurious behavior in Cornelia de Lange syndrome. Am J Ment Retard. 2006 May;111(3):184-92. doi: 10.1352/0895-8017(2006)111[184:EOSCOS]2.0.CO;2.

    PubMed 16597185
  • Bay C, Mauk J, Radcliffe J, Kaplan P. Mild Brachmann-de Lange syndrome. Delineation of the clinical phenotype, and characteristic behaviors in a six-year-old boy. Am J Med Genet. 1993 Nov 15;47(7):965-8. doi: 10.1002/ajmg.1320470706.

    PubMed 7507294
  • Bodfish JW, Symons FJ, Parker DE, Lewis MH. Varieties of repetitive behavior in autism: comparisons to mental retardation. J Autism Dev Disord. 2000 Jun;30(3):237-43. doi: 10.1023/a:1005596502855.

    PubMed 11055459
  • Didden R, Korzilius H, van Oorsouw W, Sturmey P. Behavioral treatment of challenging behaviors in individuals with mild mental retardation: meta-analysis of single-subject research. Am J Ment Retard. 2006 Jul;111(4):290-8. doi: 10.1352/0895-8017(2006)111[290:BTOCBI]2.0.CO;2.

    PubMed 16792430
  • Fisher WW, Piazza CC, Bowman LG, Amari A. Integrating caregiver report with systematic choice assessment to enhance reinforcer identification. Am J Ment Retard. 1996 Jul;101(1):15-25.

    PubMed 8827248
  • Fisher W, Piazza CC, Bowman LG, Hagopian LP, Owens JC, Slevin I. A comparison of two approaches for identifying reinforcers for persons with severe and profound disabilities. J Appl Behav Anal. 1992 Summer;25(2):491-8. doi: 10.1901/jaba.1992.25-491.

    PubMed 1634435
  • Gilliam, J. ( 2006). Gilliam Autism Rating Scale (2nd ed.). Austin, TX: Pro-Ed.

  • Heyvaert M, Maes B, Van den Noortgate W, Kuppens S, Onghena P. A multilevel meta-analysis of single-case and small-n research on interventions for reducing challenging behavior in persons with intellectual disabilities. Res Dev Disabil. 2012 Mar-Apr;33(2):766-80. doi: 10.1016/j.ridd.2011.10.010. Epub 2011 Nov 21.

    PubMed 22100975
  • Iwata BA, Dorsey MF, Slifer KJ, Bauman KE, Richman GS. Toward a functional analysis of self-injury. J Appl Behav Anal. 1994 Summer;27(2):197-209. doi: 10.1901/jaba.1994.27-197.

    PubMed 8063622
  • Iwata BA, Pace GM, Kissel RC, Nau PA, Farber JM. The Self-Injury Trauma (SIT) Scale: a method for quantifying surface tissue damage caused by self-injurious behavior. J Appl Behav Anal. 1990 Spring;23(1):99-110. doi: 10.1901/jaba.1990.23-99.

    PubMed 2335488
  • Kelley ME, Lerman DC, Van Camp CM. The effects of competing reinforcement schedules on the acquisition of functional communication. J Appl Behav Anal. 2002 Spring;35(1):59-63. doi: 10.1901/jaba.2002.35-59.

    PubMed 11936546
  • Kurtz PF, Chin MD, Huete JM, Tarbox RS, O'Connor JT, Paclawskyj TR, Rush KS. Functional analysis and treatment of self-injurious behavior in young children a summary of 30 cases. J Appl Behav Anal. 2003 Summer;36(2):205-19. doi: 10.1901/jaba.2003.36-205.

    PubMed 12858985
  • Lerman DC, Iwata BA, Shore BA, DeLeon IG. Effects of intermittent punishment on self-injurious behavior: an evaluation of schedule thinning. J Appl Behav Anal. 1997 Summer;30(2):187-201. doi: 10.1901/jaba.1997.30-187.

    PubMed 9210302
  • Martens, B. K., Witt, J. C., Elliott, S. N., & Darveaux, D. X. (1985). Teacher judgments concerning the acceptability of school-based interventions. Professional psychology: Research and practice, 16(2), 191.

Questions about this trial

What is this clinical trial studying?

A study testing ABA-based functional analysis and treatment in people with Cornelia de Lange Syndrome, run by Hugo W. Moser Research Institute at Kennedy Krieger, Inc. at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 17 inclusion and 14 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 29 Oct 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Patricia F Kurtz, PhD (443-923-2894, kurtz@kennedykrieger.org), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Behavior Problems Inventory (BPI) scores (time frame: pre-intervention (prior to admission) to post-intervention (at 2-week follow-up visit)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05829668, which also lists 22 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Oct 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in